New study points to a double-digit hike in branded drug prices, spotlighting a growing national debate
Over the last few months we’ve seen a string of big and small biopharma companies make public pledges to keep their annual drug price …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
